J.P. Morgan Securities LLC served as Coherus' financial advisor with respect to the Transaction and Latham & Watkins LLP acted as legal counsel to Coherus.

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...